Santos, D B <br/><br/>
Probucol mitigates streptozotocin-induced cognitive and biochemical changes in mice.  [electronic resource] 

 -  Neuroscience  Jan 2015 
 - 590-600 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7544 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2014.10.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholinesterase--metabolism<br/>Administration, Oral<br/>Alzheimer Disease<br/>Amyloid Precursor Protein Secretases--metabolism<br/>Animals<br/>Antioxidants--pharmacology<br/>Aspartic Acid Endopeptidases--metabolism<br/>Cholesterol--blood<br/>Cognition Disorders--drug therapy<br/>Disease Models, Animal<br/>Glutathione Peroxidase--metabolism<br/>Glutathione Reductase--metabolism<br/>Hippocampus--drug effects<br/>Male<br/>Mice<br/>Nootropic Agents--pharmacology<br/>Oxidative Stress--drug effects<br/>Probucol--pharmacology<br/>Recognition, Psychology--drug effects<br/>Streptozocin